Merck
MRK
#56
Rank
ยฃ206.43 B
Marketcap
ยฃ83.58
Share price
-1.79%
Change (1 day)
47.67%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): ยฃ2.60

According to Merck's latest financial reports the company's current EPS (TTM) is ยฃ2.67. In 2025 the company made an earnings per share (EPS) of ยฃ5.47 an increase over its 2024 EPS that were of ยฃ5.07.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ2.60-52.5%
2025ยฃ5.477.81%
2024ยฃ5.074308.46%
2023ยฃ0.12-97.32%
2022ยฃ4.3010.92%
2021ยฃ3.8884.68%
2020ยฃ2.10-27.2%
2019ยฃ2.8863.44%
2018ยฃ1.76151.11%
2017ยฃ0.70-54.58%
2016ยฃ1.5530.21%
2015ยฃ1.19-61.99%
2014ยฃ3.12180.51%
2013ยฃ1.11-31.82%
2012ยฃ1.636.62%
2011ยฃ1.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.56 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.27 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.98-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ2.71 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ21.18 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ10.87 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.92-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
ยฃ2.67 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.92 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ1.03-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel